SCHEMBL24036714

SCHEMBL24036714

COC(=O)C[C@H](NC(=O)CNC(=O)OC(C)(C)C)c1cc(Cl)cc(OC(F)(F)F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 5/20 0.43
ITGAV P06756 5/20 0.43
ITGB5 P18084 5/20 0.43
ITGB6 P18564 5/20 0.43
ITGB1 P05556 5/20 0.43
ITGA5 P08648 4/20 0.43
ITGB8 P26012 4/20 0.43
ITGA8 P53708 4/20 0.43
GPR139 Q6DWJ6 1/20 0.36
DDR1 Q08345 3/20 0.35
KCNQ3 O43525 1/20 0.34
KCNQ2 O43526 1/20 0.34
ALDH1A1 P00352 3/20 0.33
HPGD P15428 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
EGFR P00533 1/20 0.33
AURKB Q96GD4 1/20 0.33
EPAS1 Q99814 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24037104 0.89 GPR139 (0.37) GPR139ALDH1A1HPGDMEN1KMT2A
SCHEMBL25624528 0.89 EPAS1 (0.35) ITGB3ITGAVITGB5ITGB6ITGB1
SCHEMBL24036715 0.89 ITGB3 (0.43) ITGB3ITGAVITGB5ITGB6ITGB1
SCHEMBL24036750 0.86 GPR139 (0.50) ITGB3ITGAVITGB5ITGB6ITGB8
SCHEMBL25753791 0.86 ITGB3 (0.41) ITGB3ITGAVITGB5ITGB6ITGB1
SCHEMBL25753880 0.85 HPGD (0.39) ITGB3ITGAVITGB5ITGB6ITGB1
SCHEMBL25753881 0.85 HPGD (0.35) GPR139ALDH1A1HPGDMEN1KMT2A
SCHEMBL24036814 0.85 HPGD (0.35) GPR139ALDH1A1HPGDMEN1KMT2A
SCHEMBL24037106 0.84 GPR139 (0.40) ITGB3ITGAVITGB5ITGB6ITGB1
SCHEMBL24036717 0.83 KCNQ3 (0.39) ITGB3ITGAVITGB5ITGB6GPR139

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192661-A1 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE UBE CORPORATION (JP) 2023-06-22 US disclosed
WO-2023085396-A1 PHARMACEUTICAL COMPOSITION FOR PROVIDING TREATMENT FOR OR PREVENTING ALPORT SYNDROME UBE株式会社 2023-05-19 WO disclosed
WO-2021230325-A1 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE 宇部興産株式会社 2021-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192661-A1 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE DHFR, DPYD, CYP2D6 ITGB3 4177/4885ITGAV 4406/4885ITGB5 4199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.